Longitudinal magnetic resonance imaging in progressive supranuclear palsy: A new combined score for clinical trials
Sign Up to like & getrecommendations! Published in 2017 at "Movement Disorders"
DOI: 10.1002/mds.26973
Abstract: Two recent, randomized, placebo‐controlled phase II/III trials (clinicaltrials.gov: NCT01110720, NCT01049399) of davunetide and tideglusib in progressive supranuclear palsy (PSP) generated prospective, 1‐year longitudinal datasets of high‐resolution T1‐weighted three‐dimensional MRI. read more here.
Keywords: longitudinal magnetic; resonance imaging; supranuclear palsy; magnetic resonance ... See more keywords